FAIRsharing record for: Long-Acting Therapeutics Patents and Licences Database

This FAIRsharing record describes: LAPaL is a repository for information on long-acting (LA) technologies patents and licences. As of Sep 2025, it comprises 37 long-acting platform technologies and 50 LA formulations with many potential applications in the fields of HIV prevention and treatment, hepatitis B treatment, malaria treatment, type 2 diabetes and metabolic disorders management, pain management and contraception, among other applications.
In 2023, and through a collaboration with the Center of Excellence of Long Acting Therapeutics and the Long-Acting/Extended Release Antiretroviral Research Resource Program, a new section was added to LAPaL, with 10 compounds with long half-life or that could be formulated in a manner that enables extended release. We are also collaborating with major initiatives and groups, such as AVAC, to synergise efforts and support the global community to deliver effectively in the HIV prevention space.
Additionally, a visualisation tool (Landscape) is available for the selection of investigated and approved long-acting compounds in the HIV and TB fields and the related clinical trials. It provides information on the clinical trials pipeline of a set of compounds and filing data for the most advances products.